Quarter
Charts
πŸ‡ΊπŸ‡ΈUS Markets

Alerus Financial Corporation

ALRS

CIK 0000903419 Β· Quarterly mode Β· latest period FY2025 (Q4) (ending 2025-12-31) Β· sourced from SEC EDGAR

At a glance Β· FY2025 (Q4)

Revenue
$70M
↑+4.6% +$3Mvs FY2024 (Q4)
Operating Income
$67M
↑+4.2% +$3Mvs FY2024 (Q4)
Net Income
$67M
↑+4.2% +$3Mvs FY2024 (Q4)
Gross Profit
$70M
↑+4.6% +$3Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot Β· latest annual filed values Β· S&P 500 calibration

Poor
21/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    95D/E 0.10 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.05x (1.0+ = capital-efficient)
  • Growth
    32Revenue YoY +4.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ALRS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -16.5%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≀ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$31.96
Total enterprise IV
$821M
Diluted shares
0.03B
Terminal PV
$579M (70% of total)
Year-5 FCF
$68M
YearProjected FCFDiscounted PV
+1$61M$55M
+2$62M$52M
+3$64M$48M
+4$66M$45M
+5$68M$42M
Terminal$932M$579M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target β€” and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation Β· trailing 4 quarters

how the company spent its cash
Capex (TTM)
$9M
investment in PP&E
Dividends paid (TTM)
$21M
cash returned to holders
Stock buybacks (TTM)
$737K
share count reduction
Stock-based comp (TTM)
$3M
non-cash dilution

Balance sheet Β· 2025-12-31

latest filed snapshot
Total assets
$5.23B
everything owned
Total liabilities
$4.67B
everything owed
Stockholders' equity
$565M
shareholder claim
Net debt
$-8M
Net cash position ($8M)

Recent performance Β· 32 quarters

Revenue↑+4.6% +$3M
$70M
Net Income↑+225.0% +$12M
$17M
Free Cash Flow↑+659.3% +$18M
$15M

Drill down